Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CVS Health Corp (NY: CVS ) 68.14 +0.69 (+1.02%) Streaming Delayed Price Updated: 3:03 PM EDT, Apr 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 5,335,904 Open 67.20 Bid (Size) 68.14 (6) Ask (Size) 68.15 (5) Prev. Close 67.45 Today's Range 66.92 - 68.19 52wk Range 64.41 - 83.25 Shares Outstanding 1,319,574,744 Dividend Yield 3.55% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Unpacking the Latest Options Trading Trends in CVS Health Today 12:01 EDT Via Benzinga Walmart Pulls Plug On Health Centers, Telehealth; Respite For TDOC? Today 8:31 EDT Walmart is shutting down its health centers and virtual care offering, continuing a broader shakeup in telehealth. WMT stock is near a buy point. Via Investor's Business Daily Performance YTD -15.72% -15.72% 1 Month -14.35% -14.35% 3 Month -7.27% -7.27% 6 Month +0.19% +0.19% 1 Year -7.78% -7.78% More News Read More AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales April 29, 2024 Via Investor's Business Daily DoorDash: 5 Compelling Reasons to Buy the Dip April 29, 2024 Via MarketBeat Topics Death Exposures Death 3 Value Stocks to Buy on the Dip: April 2024 April 29, 2024 Via InvestorPlace Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week April 29, 2024 Via Benzinga Topics Stocks Exposures US Equities Is This Beaten-Down Dividend Stock a Buy? April 27, 2024 Via The Motley Fool Looking Into CVS Health's Recent Short Interest April 23, 2024 Via Benzinga Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost April 26, 2024 Via Benzinga 5 High-Yielding Oversold Stocks with Bullish Ratings April 26, 2024 Via MarketBeat Topics Economy Exposures Interest Rates 7 blue chip stocks to Buy on the Dip: April 2024 April 25, 2024 Via InvestorPlace 3 Absurdly Cheap Stocks to Buy and Hold for Years April 25, 2024 Via The Motley Fool Put $5,000 in These 7 Blue-Chip Stocks Today April 22, 2024 Via InvestorPlace Analyst Ratings For CVS Health April 04, 2024 Via Benzinga Beat the Dow Jones With This Cash-Gushing Dividend Stock April 21, 2024 Via The Motley Fool Topics Stocks Exposures US Equities The Smartest Dividend Stocks to Buy With $400 Right Now April 20, 2024 Via The Motley Fool The Bad News Heading Into AbbVie's First-Quarter Earnings Report April 19, 2024 Via Investor's Business Daily Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades' April 17, 2024 Via Benzinga 3 Defensive Stocks to Buy for Increased Volatility in April April 17, 2024 Via InvestorPlace 3 Weight-Loss ETFs to Profit From the Obesity Drug Boom April 17, 2024 Via InvestorPlace Topics ETFs See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina April 15, 2024 Via Benzinga Girl Power Portfolio: 3 High-Potential Stocks With Women CEOs to Buy Now April 12, 2024 Via InvestorPlace 7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape April 10, 2024 Via InvestorPlace CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access April 05, 2024 Via Benzinga Market Rally Under Pressure; Tesla, Humana In Focus: Weekly Review April 05, 2024 Via Investor's Business Daily Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
